• Je něco špatně v tomto záznamu ?

Coated chitosan pellets containing rutin intended for the treatment of inflammatory bowel disease: in vitro characteristics and in vivo evaluation

M. Rabišková, T. Bautzová, J. Gajdziok, K. Dvořáčková, A. Lamprecht, Y. Pellequer, J. Spilková,

. 2012 ; 422 (1-2) : 151-9.

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc12024285

Preparation of coated pellets intended for rutin colon delivery, their evaluation in vitro and in vivo in experimental colitis in rats was the purpose of this study. Pellets were obtained using extrusion/spheronization and coated with three types of coatings (caffeic acid/hypromellose/alginic acid; sodium alginate/hypromellose/zinc acetate; sodium alginate/chitosan). Dissolution using buffers of pH values, β-glucosidase and times corresponding to gastrointestinal tract (GIT) was provided. Pellets coated with alginate/chitosan showed low rutin dissolution (12-14%) in upper GIT conditions and fast release (87-89%) under colon conditions; that is a good presumption of intended rutin release. After colitis induction and development, the rats were treated with pellets and rutin solution administered orally, solution also rectally. Colon/body weight ratio, myeloperoxidase activity and histological evaluation were performed. Rutin was able to promote colonic healing at the dose of 10mg/kg: colon/body weight ratio decreased and myeloperoxidase activity was significantly suppressed. Pellets coated with alginate/chitosan applied orally and rutin solution administered rectally showed the best efficacy. The combination of rutin as natural product, mucoadhesive chitosan degraded in the colon and sodium alginate as the main coating substance in the form of pellets create a promising preparation for therapy of this severe illness.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12024285
003      
CZ-PrNML
005      
20121207110453.0
007      
ta
008      
120815s2012 ne f 000 0#eng||
009      
AR
024    7_
$a 10.1016/j.ijpharm.2011.10.045 $2 doi
035    __
$a (PubMed)22079717
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Rabišková, Miloslava $u Department of Pharmaceutics, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackého 1-3, 612 42 Brno, Czech Republic. rabiskovam@vfu.cz
245    10
$a Coated chitosan pellets containing rutin intended for the treatment of inflammatory bowel disease: in vitro characteristics and in vivo evaluation / $c M. Rabišková, T. Bautzová, J. Gajdziok, K. Dvořáčková, A. Lamprecht, Y. Pellequer, J. Spilková,
520    9_
$a Preparation of coated pellets intended for rutin colon delivery, their evaluation in vitro and in vivo in experimental colitis in rats was the purpose of this study. Pellets were obtained using extrusion/spheronization and coated with three types of coatings (caffeic acid/hypromellose/alginic acid; sodium alginate/hypromellose/zinc acetate; sodium alginate/chitosan). Dissolution using buffers of pH values, β-glucosidase and times corresponding to gastrointestinal tract (GIT) was provided. Pellets coated with alginate/chitosan showed low rutin dissolution (12-14%) in upper GIT conditions and fast release (87-89%) under colon conditions; that is a good presumption of intended rutin release. After colitis induction and development, the rats were treated with pellets and rutin solution administered orally, solution also rectally. Colon/body weight ratio, myeloperoxidase activity and histological evaluation were performed. Rutin was able to promote colonic healing at the dose of 10mg/kg: colon/body weight ratio decreased and myeloperoxidase activity was significantly suppressed. Pellets coated with alginate/chitosan applied orally and rutin solution administered rectally showed the best efficacy. The combination of rutin as natural product, mucoadhesive chitosan degraded in the colon and sodium alginate as the main coating substance in the form of pellets create a promising preparation for therapy of this severe illness.
650    _2
$a aplikace orální $7 D000284
650    _2
$a algináty $x chemie $7 D000464
650    _2
$a zvířata $7 D000818
650    _2
$a antiflogistika $x aplikace a dávkování $x chemie $x farmakologie $7 D000893
650    _2
$a pufry $7 D002021
650    _2
$a kyseliny kávové $x chemie $7 D002109
650    _2
$a chemie farmaceutická $7 D002626
650    _2
$a chitosan $x chemie $7 D048271
650    _2
$a kolitida $x chemicky indukované $x farmakoterapie $x patologie $7 D003092
650    _2
$a kolon $x účinky léků $x patologie $7 D003106
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a příprava léků $7 D004339
650    _2
$a léky implantované $7 D004343
650    _2
$a stabilita léku $7 D004355
650    _2
$a gastrointestinální látky $x aplikace a dávkování $x chemie $x farmakologie $7 D005765
650    _2
$a kyselina glukuronová $x chemie $7 D020723
650    _2
$a kyseliny hexuronové $x chemie $7 D006603
650    _2
$a koncentrace vodíkových iontů $7 D006863
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a methylcelulosa $x analogy a deriváty $x chemie $7 D008747
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    _2
$a rutin $x aplikace a dávkování $x chemie $x farmakologie $7 D012431
650    _2
$a rozpustnost $7 D012995
650    _2
$a farmaceutická technologie $x metody $7 D013678
650    _2
$a časové faktory $7 D013997
650    _2
$a kyselina trinitrobenzensulfonová $7 D014302
650    _2
$a octan zinečnatý $x chemie $7 D019345
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Bautzová, Tereza
700    1_
$a Gajdziok, Jan
700    1_
$a Dvořáčková, Kateřina
700    1_
$a Lamprecht, Alf
700    1_
$a Pellequer, Yann
700    1_
$a Spilková, Jiřina
773    0_
$w MED00002359 $t International journal of pharmaceutics $x 1873-3476 $g Roč. 422, č. 1-2 (2012), s. 151-9
856    41
$u https://pubmed.ncbi.nlm.nih.gov/22079717 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m
990    __
$a 20120815 $b ABA008
991    __
$a 20121207110527 $b ABA008
999    __
$a ok $b bmc $g 946433 $s 781613
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2012 $b 422 $c 1-2 $d 151-9 $i 1873-3476 $m International journal of pharmaceutics $n Int. j. pharm. $x MED00002359
LZP    __
$a Pubmed-20120815/12/02

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...